Form 4 Tracker
Rapport Therapeutics, Inc.
RAPP

40 insider filings · Latest: Oct 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 30, 2026Jun 30 8:33 PMCHERYL GAULT
Proposed Sale
10,000$40.39$403.9K—

View →

Jun 29, 2026Jun 29 8:45 PMAbraham N. Ceesay
Proposed Sale
99,480$40.39$4.0M—

View →

May 26, 2026May 28 8:15 PMThird Rock Ventures V, L.P.10% Owner
Sale
18,572$40.05$743.8K6,280,525(D)

View →

May 26, 2026May 27 1:16 PMThird Rock Ventures V, L.P.
Proposed Sale
18,572$40.00$742.9K—

View →

May 11, 2026May 13 11:06 PMThird Rock Ventures V, L.P.10% Owner
Sale
133,618$40.24$5.4M6,299,097(D)

View →

May 8, 2026May 11 9:07 PMThird Rock Ventures V, L.P.10% Owner
Sale
5,018$40.31$202.3K6,432,715(D)

View →

May 7, 2026May 11 9:07 PMThird Rock Ventures V, L.P.10% Owner
Sale
271,495$40.12$10.9M6,437,733(D)

View →

May 11, 2026May 11 8:25 PMThird Rock Ventures V, L.P.
Proposed Sale
133,618$40.25$5.4M—

View →

May 8, 2026May 8 8:57 PMThird Rock Ventures V, L.P.
Proposed Sale
5,018$40.31$202.3K—

View →

May 7, 2026May 7 8:44 PMThird Rock Ventures V, L.P.
Proposed Sale
271,495$40.12$10.9M—

View →

Apr 17, 2026Apr 21 11:36 PMThird Rock Ventures V, L.P.10% Owner
Sale
426,005$40.32$17.2M6,709,228(D)

View →

Apr 17, 2026Apr 21 8:55 PMKrishnaswamy YeleswaramChief Development Officer
Sale
20,225$39.99$808.8K246,426(D)

View →

Apr 17, 2026Apr 17 8:37 PMKRISHNASWAMY YELESWARAM
Proposed Sale
20,225$39.54$799.7K—

View →

Apr 17, 2026Apr 17 8:25 PMThird Rock Ventures V, L.P.
Proposed Sale
426,005$40.32$17.2M—

View →

Apr 14, 2026Apr 14 8:13 PMKrishnaswamy YeleswaramChief Development Officer
Sale
10,200$35.08$357.8K266,651(D)

View →

Apr 13, 2026Apr 14 8:13 PMKrishnaswamy YeleswaramChief Development Officer
Sale
9,165$34.97$320.5K276,851(D)

View →

Apr 10, 2026Apr 14 8:13 PMKrishnaswamy YeleswaramChief Development Officer
Sale
500$34.98$17.5K286,016(D)

View →

Apr 13, 2026Apr 13 8:37 PMKRISHNASWAMY YELESWARAM
Proposed Sale
19,365$34.17$661.7K—

View →

Apr 10, 2026Apr 10 8:34 PMKRISHNASWAMY YELESWARAM
Proposed Sale
500$34.22$17.1K—

View →

Apr 8, 2026Apr 9 8:30 PMKrishnaswamy YeleswaramChief Development Officer
Sale
360$34.90$12.6K286,516(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 10, 2026Jun 10 9:57 PMJohn MaraganoreDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:52 PMRobert J PerezDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:46 PMSteven M PaulDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:28 PMPaul M SilvaDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:26 PMJames HealyDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:25 PMReid M HuberDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:24 PMWendy B. YoungDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:23 PMRamiro SanchezDirector
Grant/Award
15,200$35.2115,200(D)

View →

Feb 19, 2026Feb 20 12:05 AMDavid BredtChief Scientific Officer
Option Exercise
6,000$1.8088,080(D)

View →

Feb 2, 2026Feb 4 9:15 PMJeffrey SevignyChief Medical Officer
Grant/Award
130,000$27.75130,000(D)

View →

Feb 2, 2026Feb 4 9:14 PMAbraham CeesayDirector, Chief Executive Officer
Grant/Award
428,000$27.75428,000(D)

View →

Feb 2, 2026Feb 4 9:12 PMTroy A. IgnelziChief Financial Officer
Grant/Award
148,000$27.75148,000(D)

View →

Feb 2, 2026Feb 4 9:11 PMKrishnaswamy YeleswaramChief Development Officer
Grant/Award
120,000$27.75120,000(D)

View →

Feb 2, 2026Feb 4 9:09 PMDavid BredtChief Scientific Officer
Grant/Award
103,000$27.75103,000(D)

View →

Feb 2, 2026Feb 4 9:02 PMCheryl GaultChief Operating Officer
Grant/Award
132,000$27.75132,000(D)

View →